We divided the samples into two subgroups (high and low CDCA8 expression level subgroups) based on the CDCA8 gene expression values in these 414 bladder cancer samples and used GSEA analysis to predict the pathways that CDCA8 may affect. The gene discussed is CDCA8; the disease is urinary bladder cancer.